The effect of single dose of ketamine injection in reducing suicidal ideation in type 1 bipolardisorder patients in the depressive phase

Phase 2

Recruiting

• Conditions: type 1 bipolardisorder patients in the depressive phase.; Mood disorder due to known physiological condition with depressive features; F06.31

• Registration Number: IRCT20141209020258N182
• Lead Sponsor: Arak University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 124

Inclusion Criteria

Patients with bipolar disorder type 1 in the depressive phase according to DSM5 criteria and having suicidal thoughts
No drug use in the last month.
Not receiving electric shock during the last month and during recent hospitalization.
15 to 65 years
No mental retardation
Absence of underlying disease
No history of stroke, seizure, brain tumor, dementia and being in delirium phase
No history of head injury and loss of consciousness
Not using all kinds of drugs and alcohol in the past month

Exclusion Criteria

Lack of consent of the patient or guardian to participate in the study
Drug sensitivity

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Suicidal ideation. Timepoint: Start of the study, 2, 24 and 72 hours after the start of the study. Method of measurement: Beck Suicidal Ideation Scale.